These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

149 related items for PubMed ID: 1724082

  • 1. Effects of proteolytic enzyme inhibitors on the nasal absorption of vasopressin and an analogue.
    Morimoto K, Yamaguchi H, Iwakura Y, Miyazaki M, Nakatani E, Iwamoto T, Ohashi Y, Nakai Y.
    Pharm Res; 1991 Sep; 8(9):1175-9. PubMed ID: 1724082
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Gabexate mesilate (FOY) and aprotinin. A comparative study of the effects on trypsin-induced activation of the kinin and complement systems in vivo and in vitro.
    Lasson A, Balldin G, Ohlsson K.
    Hoppe Seylers Z Physiol Chem; 1984 Dec; 365(12):1409-15. PubMed ID: 6084637
    [Abstract] [Full Text] [Related]

  • 7. Influence of culturing temperature and proteinase inhibitors on the spontaneously occurring changes in the organ culture of psoriatic skin.
    Ikeda S, Morioka S, Ogawa H.
    J Dermatol Sci; 1990 Mar; 1(2):85-92. PubMed ID: 1713057
    [Abstract] [Full Text] [Related]

  • 8. The proteinase inhibitor camostat mesilate suppresses pancreatic pain in rodents.
    Ishikura H, Nishimura S, Matsunami M, Tsujiuchi T, Ishiki T, Sekiguchi F, Naruse M, Nakatani T, Kamanaka Y, Kawabata A.
    Life Sci; 2007 May 01; 80(21):1999-2004. PubMed ID: 17433371
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Elimination of infused arginine-vasopressin and its long-acting deaminated analogue in rats.
    Gazis D, Sawyer WH.
    J Endocrinol; 1978 Aug 01; 78(2):179-86. PubMed ID: 702013
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Inhibition of phospholipase A2 by gabexate mesilate, camostate and aprotinine.
    Freise J, Magerstedt P, Schmid K.
    Enzyme; 1983 Aug 01; 30(3):209-12. PubMed ID: 6194983
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Cellular (thrombocytes, granulocytes) effects of proteinase inhibitors--gabexylate, gabexate mesilate (FOY) and aprotinin.
    Redl H, Schlag G, Paul E, Schiesser A.
    Resuscitation; 1986 Sep 01; 14(1-2):81-90. PubMed ID: 2431445
    [Abstract] [Full Text] [Related]

  • 16. Effects of various protease inhibitors on the intestinal absorption and degradation of insulin in rats.
    Yamamoto A, Taniguchi T, Rikyuu K, Tsuji T, Fujita T, Murakami M, Muranishi S.
    Pharm Res; 1994 Oct 01; 11(10):1496-500. PubMed ID: 7855059
    [Abstract] [Full Text] [Related]

  • 17. Gabexate and camostat, synthetic proteinase inhibitors, as direct inducing factors of water and bicarbonate secretion in the isolated and blood-perfused dog pancreas.
    Horiuchi A, Iwatsuki K, Yonekura H, Ren LM, Chiba S.
    J Pharmacol Exp Ther; 1990 Jan 01; 252(1):320-6. PubMed ID: 1688943
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.